Vascular endothelial growth factor (VEGF) is a well-known angiogenic factor that plays a
critical role in various physiological and pathological processes. VEGF also contributes to …

BACKGROUND The use of antenatal steroid therapy is common in pregnancy. In early
pregnancy, steroids may be used in women for the treatment of recurrent miscarriage or fetal …

Objective: The objective is to provide clinical guidelines for the management of thyroid
problems present during pregnancy and in the postpartum. Participants: The Chair was …

Many common disorders of pregnancy are attributed to insufficient invasion of the uterine
lining by trophoblast, fetal cells that are the major cell type of the placenta. Interactions …

Recurrent miscarriage (RM;≥ 3 consecutive early pregnancy losses) affects around 1% of
fertile couples. Parental chromosomal anomalies, maternal thrombophilic disorders and …

Ziel Offizielle Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe
(DGGG), der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (ÖGGG) und …

BACKGROUND Pre-eclampsia, small-for-gestational-age infants, preterm birth and
recurrent miscarriage complicate a significant number of pregnancies. The vascular …

Objective To study the possible relationship between sperm aneuploidy, sperm DNA
integrity, chromatin packaging, traditional semen parameters, and recurrent pregnancy loss …

Immunological rejection of the fetus due to recognition of paternal antigens by the maternal
immune system, resulting in abnormal immune cells and cytokine production, is postulated …

Although recurrent miscarriage (RM) affects only 1–3% of couples, it has a major influence
on the wellbeing and psychosocial status of patients. Therefore, research into improved …